Easton Pharmaceuticals Enters Into Cancer Drug Industry by Acquiring Initial Minority Ownership Interest in Experimental Cancer Drug "XILIVE" With 12 Month Option to Purchase Remaining Interest; Preliminary Feedback Extremel